Helping children with growth failure due to tyrosine kinase inhibitor drugs requires knowledge of the pathogenesis of the problem

dc.contributor.author	Rivas Crespo, Maximiliano Francisco
dc.date.accessioned	2017-10-31T10:48:12Z
dc.date.available	2017-10-31T10:48:12Z
dc.date.issued	2017
dc.identifier.citation	Pediatric Blood and Cancer, 64(12), e26672 (2017); doi:10.1002/pbc.26672
dc.identifier.issn	1545-5009
dc.identifier.uri	http://hdl.handle.net/10651/44074
dc.language.iso	eng
dc.relation.ispartof	Pediatric Blood and Cancer
dc.rights	©,
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020485560&doi=10.1002%2fpbc.26672&partnerID=40&md5=65a4297f9245161ba7da4df166f3b86e
dc.title	Helping children with growth failure due to tyrosine kinase inhibitor drugs requires knowledge of the pathogenesis of the problem
dc.type	journal article
dc.identifier.doi	10.1002/pbc.26672
dc.relation.publisherversion	http://dx.doi.org/10.1002/pbc.26672

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.